TRPM2 and Behcet disease: Research has also unveiled that TNF-α, an abnormally elevated cytokine in neutrophils treated with BD serum, can induce the expression of TRPM2 channels, and classic TNF inhibitors can block this effect, effectively alleviating the overactivation of BD neutrophils and vascular inflammation 171.